Biosensors for clinical research

NeuDrive’s biosensors detect bioconjugate chemistry coupled to the gate electrode of the OTFT.  The integration of biosensors with signal amplification/processing logic gives NeuDrive a versatile platform technology for developing low cost customised biosensor arrays and will position NeuDrive as a valuable partner for the pharmaceutical and biotechnology industries.  NeuSensor technology will enhance our partners capabilities in such areas as drug candidate selection for hard to drug targets, identification of biomarkers for diseases (including the development of companion diagnostics) and point of care clinical monitoring.


Logic and AI devices

High mobility at short channel length has enabled ring oscillators with operating frequencies of over 1MHz to be achieved making OTFT a good candidate for logic applications, notably where integration on flexible substrates is required. FlexOSTM OTFT device technology can be used to make logic circuits using a similar fabrication process to flexible backplanes. In connection with its development of healthcare applications NeuDrive is developing a range of scalable logic circuit functions suitable for manipulation and analysis of the electronic signals generated by its biosensor arrays.  NeuDrive’s technology thus offers the potential to integrate machine learning and artificial intelligence capability with biochemical analysis.

Fabrication and Processing

NeuDrive’s materials can be processed using a range of industry standard techniques for flat panel display backplane fabrication on plastic or rigid substrates. With ambient and low temperature solution processing they are a good match for conventional a-Si backplane infrastructure. Formulations can be adjusted to suit the requirements of a range of process equipment at a range of substrate sizes, typically being 370mm x 470mm (Gen2) for pilot scale trials. Compatibility with display manufacturing infrastructure enables NeuDrive’s technology for large biosensor arrays to be fabricated at an economic cost point that could not be achieved with Silicon CMOS processing.


Material to Device